Skip to main content

Weather Alert

Due to hurricane Idalia, our Patient Service Centers in affected areas may be closed. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics Home

Patient-minded Neurology

This episode features Dr Michael Racke discussing the evolution of treating neurologic disease to detect disease early and focus on prevention. In this session, Dr Racke discusses:

  • How diagnostics and treatment has evolved for multiple sclerosis
  • Treating patients at the first incidence of neurologic disease for optimal outcomes
  • How health systems can address the needs of patients with complex neurologic conditions to minimize the human and economic toll of disease

Dr. Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. Dr. Racke is a leader in the field of neurology and neuroimmunology. Dr. Racke is the author of more than 200 peer-reviewed papers, books, chapters, and reviews spanning the pathogenesis of neuroimmunologic diseases. He continues to serve on several national professional society committees.

Date: Monday, June 14, 2021

Author(s): Racke, MK

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2023 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.